×

img Acces sibility Controls

Research Projects Banner

Research Projects

Alpha V Beta 3 Integrin Aspired Vesicular Nanohybrids Based Neoadjuvant Therapy for Locally Advanced Colon Cancer

Implementing Organization

National Institute of Pharmaceutical Education And Research (NIPER) Ahmedabad, Gujarat
Principal Investigator
Dr. Aakanchha Jain
National Institute of Pharmaceutical Education And Research (NIPER) Ahmedabad, Gujarat

About

Neoadjuvant therapy is a treatment used to reduce tumor size or make it easier to remove, used for various types of cancer. Nanomedicine, using nanotechnology, can diagnose, treat, and prevent diseases. In the context of multidrug resistant colon cancer, nanomedicine offers a promising solution by allowing targeted delivery of therapeutic agents directly to the tumor site. The results could impact the field by improving cancer treatment with lesser morbidity, mortality, and metastasis, and potentially reducing the need for surgery. Methodology involved evaluating particle size, surface charge, loading efficiency, particle density, in-vitro drug release, and stability of established vesicular nanohybrids.
Funding Organization
Funding Organization
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Start Year
2023
End Year
2025
Sanction Amount
₹ 31.35 L
Status
Completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop